TY - ECHAP KW - leprosy KW - Polymorphisms KW - Pattern-recognition receptors KW - Mycobacterium leprae KW - Genetic Variation AU - Jorge KTOS AU - Soriani FM AB -

Mycobacterium leprae is a highly infectious and low pathogenic microorganism that is the causal agent of leprosy. The differences in vulnerability to leprosy, the spectral immune response, and the clinical manifestations of this disease are related to different genetic backgroundsamongindividuals.Inthissense,geneticvariants,especiallyingenesrelated to mycobacteria recognition and host immune response, may be key factors to explain individual susceptibility and resistance to leprosy and their conditions. In this chapter, studies regarding association of genetic variants in pattern-recognition receptors (PRRs) and leprosy will be reviewed revealing the importance of molecules such as Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain-containing protein 2 (NOD2) in leprosy initiation and maintenance.

BT - Hansen’s Disease LA - eng N2 -

Mycobacterium leprae is a highly infectious and low pathogenic microorganism that is the causal agent of leprosy. The differences in vulnerability to leprosy, the spectral immune response, and the clinical manifestations of this disease are related to different genetic backgroundsamongindividuals.Inthissense,geneticvariants,especiallyingenesrelated to mycobacteria recognition and host immune response, may be key factors to explain individual susceptibility and resistance to leprosy and their conditions. In this chapter, studies regarding association of genetic variants in pattern-recognition receptors (PRRs) and leprosy will be reviewed revealing the importance of molecules such as Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain-containing protein 2 (NOD2) in leprosy initiation and maintenance.

PB - IntechOpen PY - 2018 EP - 17 T2 - Hansen’s Disease TI - Genetic variation in pattern-recognition receptors and association with leprosy UR - https://cdn.intechopen.com/pdfs/59506.pdf ER -